Application no. and date | 12801539.3 (espacenet) (Federated) (European Patent Register), 20121210 | Patent/reg. no. and date | DK/EP 2793876, 20231004 | Publication date | 20141029 | Priority no. and date | EP 11194292, 20111219, EP 12004652, 20120621, US 201261663761 P, 20120625, US 201213654632, 20121018 | EP pub. no. and date |
EP 2793876 20141029 | Effective date | | Applicant/owner | Kahrs, Bjoern Colin, Via Costa di Mezzo 54
6614 Brissago, CH | Applicant ref. no. | | Inventor | Kahrs, Bjoern Colin, Via Costa di Mezzo 54
6614 Brissago, CH | Representative | | Opponent | | IPC Class | A61K 31/05 (2006.01) , A61K 31/12 (2006.01) , A61K 31/16 (2006.01) , A61K 31/19 (2006.01) , A61K 31/216 (2006.01) , A61K 31/225 (2006.01) , A61K 31/26 (2006.01) , A61K 31/385 (2006.01) , A61K 31/4439 (2006.01) , A61K 31/47 (2006.01) , A61K 31/70 (2006.01) , A61K 45/06 (2006.01) , A61P 1/04 (2006.01) , A61P 17/06 (2006.01) , A61P 17/14 (2006.01) , A61P 21/04 (2006.01) , A61P 5/48 (2006.01) | Title | PHARMACEUTICAL COMPOSITIONS COMPRISING GLITAZONES AND NRF2 ACTIVATORS | Int. application no. | EP2012074915 | Int. publication no. | WO2013092269 | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|